|
Pompe Program Update
|
Genzyme |
|
Genzyme Receives Complete Response Letter from FDA on Lumizyme Application
|
Genzyme |
|
Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe
|
Amicus |
|
European Authorities Approve Larger-Scale Production of Genzyme’s Myozyme
|
Genzyme |
|
Genzyme Receives Positive Opinion on Myozyme from CHMP in Europe
|
Genzyme |
|
Myozyme Program Update - Global Version
|
Genzyme |
|
Myozyme (2000L) Program Update--US version
|
Genzyme |
|
Guidance to the Pompe Community on the Management of Myozyme Supply
|
IPA/Genzyme |
|
IPA Statement Regarding the Management of Myozyme Supply - Advice to Patient Groups
|
IPA |
|
IPA Statement Regarding the Management of Myozyme Supply - Advice to Pompe Patients
|
IPA |
